89 related articles for article (PubMed ID: 11550317)
1. Immunohistochemical staining for ganglioside GD1b as a diagnostic and prognostic marker for primary human brain tumors.
Comas TC; Tai T; Kimmel D; Scheithauer BW; Burger PC; Pearl DK; Jewell SD; Yates AJ
Neuro Oncol; 1999 Oct; 1(4):261-7. PubMed ID: 11550317
[TBL] [Abstract][Full Text] [Related]
2. Gangliosides as diagnostic markers of human astrocytomas and primitive neuroectodermal tumors.
Sung CC; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
Cancer; 1994 Dec; 74(11):3010-22. PubMed ID: 7954264
[TBL] [Abstract][Full Text] [Related]
3. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
Li J; Pearl DK; Pfeiffer SE; Yates AJ
J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
[TBL] [Abstract][Full Text] [Related]
4. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
5. Glycolipids and myelin proteins in human oligodendrogliomas.
Sung CC; Collins R; Li J; Pearl DK; Coons SW; Scheithauer BW; Johnson PC; Yates AJ
Glycoconj J; 1996 Jun; 13(3):433-43. PubMed ID: 8781974
[TBL] [Abstract][Full Text] [Related]
6. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
[TBL] [Abstract][Full Text] [Related]
7. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of urokinase-type plasminogen activator in human gliomas.
Hsu DW; Efird JT; Hedley-Whyte ET
Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873
[TBL] [Abstract][Full Text] [Related]
9. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
Katsetos CD; Del Valle L; Geddes JF; Assimakopoulou M; Legido A; Boyd JC; Balin B; Parikh NA; Maraziotis T; de Chadarevian JP; Varakis JN; Matsas R; Spano A; Frankfurter A; Herman MM; Khalili K
Arch Pathol Lab Med; 2001 May; 125(5):613-24. PubMed ID: 11300931
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival.
Schittenhelm J; Trautmann K; Tabatabai G; Hermann C; Meyermann R; Beschorner R
Mod Pathol; 2009 Dec; 22(12):1600-11. PubMed ID: 19767728
[TBL] [Abstract][Full Text] [Related]
11. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
12. Paraffin section p53 protein immunohistochemistry in neuroectodermal tumors.
Ng HK; Lo SY; Huang DP; Poon WS
Pathology; 1994 Jan; 26(1):1-5. PubMed ID: 8165016
[TBL] [Abstract][Full Text] [Related]
13. Distribution of 4-hydroxynonenal-protein conjugates as a marker of lipid peroxidation and parameter of malignancy in astrocytic and ependymal tumors of the brain.
Juric-Sekhar G; Zarkovic K; Waeg G; Cipak A; Zarkovic N
Tumori; 2009; 95(6):762-8. PubMed ID: 20210242
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside patterns in neuroepithelial tumors of childhood.
Pan XL; Izumi T; Yamada H; Akiyoshi K; Suenobu S; Yokoyama S
Brain Dev; 2000 May; 22(3):196-8. PubMed ID: 10814905
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.
Valkonen M; Haapasalo H; Rilla K; Tyynelä-Korhonen K; Soini Y; Pasonen-Seppänen S
BMC Cancer; 2018 Jun; 18(1):664. PubMed ID: 29914429
[TBL] [Abstract][Full Text] [Related]
18. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
19. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
